Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects

Pain
Elon EisenbergDorit Pud

Abstract

The large inter-individual variability in the magnitude of analgesia in response to opioids and the high prevalence of adverse events associated with their use underline the clinical importance of being able to predict who will or will not respond to opioid treatment. The present study used both static and dynamic quantitative sensory testing (QST) on 40 healthy volunteers in order to test whether this methodology can predict the analgesic effects of oral oxycodone, as compared to a placebo, on latency to onset, pain intensity, and tolerance to the cold pressor test (CPT). Static QST consisted of measuring heat and cold pain thresholds. Dynamic QST included measurements of the magnitude of the diffuse noxious inhibitory control (DNIC)-like effect and of temporal summation (TS). Results showed that oxycodone, but not the placebo, significantly elevated the latency and tolerance to cold pain and significantly reduced pain intensity. The static QST results showed that heat pain thresholds predicted the magnitude of reduction in pain intensity in response to oxycodone treatment (F((1,22))=5.63, p=0.027, R(2)=0.17). The dynamic QST results showed that TS predicted the effect of oxycodone on the tolerance to CPT (F((1,38))=9.11, p=0....Continue Reading

References

Jun 5, 1992·European Journal of Pharmacology·D BouhassiraD Le Bars
Jan 1, 1992·Pain·D Le BarsT De Broucker
Dec 1, 1991·Neuropharmacology·A H DickensonH J McQuay
Nov 18, 1998·Annals of Neurology·A L OaklanderR A Meyer
Aug 26, 2004·British Journal of Clinical Pharmacology·Michael GrachElon Eisenberg
Nov 29, 2005·European Journal of Pain : EJP·Dorit PudElon Eisenberg
Nov 23, 2006·The Journal of Pain : Official Journal of the American Pain Society·Lihi StrulovLior Lowenstein
Jan 8, 2008·Journal of Pain and Symptom Management·Meredith NobleKaren Schoelles
Apr 22, 2009·The Journal of Pain : Official Journal of the American Pain Society·Lars Arendt-Nielsen, David Yarnitsky
Apr 29, 2009·The Journal of Pain : Official Journal of the American Pain Society·Irit Weissman-FogelMichal Granot
May 5, 2009·The Journal of Pain : Official Journal of the American Pain Society·Roger B FillingimJoseph L Riley
Jul 2, 2009·Mayo Clinic Proceedings·Howard S Smith

❮ Previous
Next ❯

Citations

Feb 6, 2013·Medical & Biological Engineering & Computing·Steven E HarteGrant H Kruger
Aug 15, 2013·Current Pain and Headache Reports·Yelena Granovsky
Jun 13, 2012·Experimental and Clinical Psychopharmacology·Lisa S MiddletonSharon L Walsh
Jun 14, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jiang-Ti KongSean Mackey
Dec 2, 2011·Health and Quality of Life Outcomes·Daniel Ciampi de AndradeManoel J Teixeira
Aug 9, 2012·Expert Opinion on Drug Metabolism & Toxicology·Marieke Niesters, Albert Dahan
Sep 16, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Erica SuzanElon Eisenberg
Sep 10, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Yenisel Cruz-Almeida, Roger B Fillingim
May 10, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Vitaly NapadowAjay D Wasan
Oct 9, 2012·Peptides·Richard J Bodnar
Sep 25, 2015·Pain Management·Carlos J Roldan, Salahadin Abdi
May 10, 2013·European Journal of Pain : EJP·K GrosenA M Drewes
Jun 23, 2015·European Journal of Pain : EJP·M GramA M Drewes
Dec 17, 2014·Rheumatology International·Eric OsgoodNathaniel Katz
Feb 5, 2013·The Journal of Pain : Official Journal of the American Pain Society·Stephen BruehlYu Lin
Dec 5, 2014·Korean journal of anesthesiology·Hyeon Jeong Lee, David C Yeomans
Sep 30, 2014·Anesthesiology·Kristin L SchreiberRobert R Edwards
Jun 24, 2016·Pain Practice : the Official Journal of World Institute of Pain·Martin F BjurströmDavid C Chen
May 18, 2016·The Clinical Journal of Pain·Stephen BruehlChristopher R France
Apr 4, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Avi A Weinbroum
Jan 25, 2018·European Journal of Pain : EJP·J SchliessbachM Curatolo
Jan 20, 2018·Pain Practice : the Official Journal of World Institute of Pain·Abdullah Mohammad AlqarniRamakrishnan Mani
Dec 10, 2019·Scandinavian Journal of Pain·Rania NuwailatiMark Drangsholt
Aug 16, 2014·The Journal of Pharmacology and Experimental Therapeutics·Wendy J WinchesterDavid S Reynolds
Oct 5, 2019·Pain Reports·Claudia M CampbellSrinivasa Raja
Feb 27, 2021·Scientific Reports·Pablo de la CobaGustavo A Reyes Del Paso
Aug 3, 2020·Burns : Journal of the International Society for Burn Injuries·E CroftonJ Strong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.